Month: May 2021
Business strategy
Diagnostics Biocortech is completing clinical proof of concept of its in vitro diagnostics tests for disease management of brain disorders and is interested in collaborating on their regulatory development, industrialization, marketing and commercialization, with industry partner(s) having a franchise in in vitro diagnostic market. Biocortech contemplates possibilities to develop and commercialize diagnostic tests for niche…
Read MoreHome
Biocortech is focusing on developing diagnostic application of receptor editing, an emerging field of rapidly growing interest that the company pioneered for the last years. Biocortech is now addressing the emerging market of biological testing of neuropsychiatric diseases and aiming at being an early entrant in the market of biological testing of depression, with a proprietary…
Read More